<unk>  is a Endocrine-Metabolic Agent that is FDA approved for the treatment of inhibition of premature LH surges in women undergoing controlled ovarian hyperstimulation.   Common adverse reactions include Abdominal Pain (gynecological), Headache, Ovarian Hyperstimulation Syndrome, Vaginal Bleeding.
Ganirelix
Cobicistat
Simfibrate
Migalastat
Iofendylate
Mevastatin
Oprelvekin
Pravastatin